Royal Bank of Canada’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Royal Bank of Canada’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-570	Closed	–	–	7705
2024 Q2	$0	Hold	570	–	–	﹤0.01%	7705
2024 Q1	$1K	Hold	570	–	–	﹤0.01%	6912
2023 Q4	$1K	Sell	570 -70	-11%	-$93	﹤0.01%	7024
2023 Q3	$1K	Buy	+640	New	+$1.55K	﹤0.01%	6984
2023 Q2	–	Sell	-217	Closed	-$1K	–	7786
2023 Q1	$1K	Hold	217	–	–	﹤0.01%	6967
2022 Q4	$1K	Sell	217 -33	-13%	-$182	﹤0.01%	7114
2022 Q3	$1K	Buy	250 +33	+15%	+$232	﹤0.01%	7319
2022 Q2	$2K	Hold	217	–	–	﹤0.01%	7022
2022 Q1	$3K	Hold	217	–	–	﹤0.01%	7420
2021 Q4	$5K	Hold	217	–	–	﹤0.01%	7235
2021 Q3	$4K	Buy	+217	New	+$4.07K	﹤0.01%	7218

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Royal Bank of Canada's BTCY Position: Q3 2024 in Review

Royal Bank of Canada sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 570 shares.

Royal Bank of Canada first reported a position in BTCY in Q3 2021 and held it in 11 quarters. The position peaked at $5K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

Royal Bank of Canada reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 570 Biotricity, Inc. Common Stock shares in Q3 2024.
Royal Bank of Canada first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Royal Bank of Canada's Biotricity, Inc. Common Stock position peaked at $5K in Q4 2021.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.